Efficacy of olanzapine in social anxiety disorder: A pilot study

Journal of Psychopharmacology

Volumn 16, Issue 4, 2002, Pages 365-368

  Barnett, Stewart D ^a   Kramer, Michelle L ^a   Casat, Charles D ^b   Connor, Kathryn M ^a   Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Behavioural Health Center   (United States)

Author keywords

Brief Social Phobia Scale; Olanzapine; Social anxiety disorder; Social Phobia Inventory

Indexed keywords

OLANZAPINE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE;

ADULT; AGED; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; TREATMENT OUTCOME; XEROSTOMIA; ADOLESCENT; MIDDLE AGED; PHOBIA; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOBIC DISORDERS; PILOT PROJECTS; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0036902244     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600412     Document Type: Article

References (22)

1. Ballenger J C, Davidson J R, Lecrubier Y, Nutt D J, Bobes J, Beidel D C, Ono Y, Westenberg H G (1998) Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 59 (Suppl. 17): 54-60
2. Barnes T R E (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676
3. Bymaster F P, Calligaro D O, Falcone J F, Marsh R D, Moore N A, Tye N C, Seeman P, Wong D T (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96
4. Connor K M, Davidson J R, Churchill L E, Sherwood A, Foa E, Weisler R H (2000) Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry 176: 379-386
5. Davidson J R, Potts N, Richichi E, Krishnan R, Ford S M, Smith R, Wilson W H (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13: 423-428
6. Davidson J R, Miner C M, DeVeaugh-Geiss J, Tupler L A, Colket J T, Potts N L (1997) The Brief Social Phobia Scale: A psychometric evaluation. Psychol Med 27: 161-166
7. Gelernter C S, Uhde T W, Cimbolic P, Arnkoff D B, Vittone B J, Tancer M E, Bartko J J (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 48: 938-945
8. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, Rev Edn., p. 534. NIMH, Rockville, MD
9. Hollander E, Kwon J, Weiller F, Cohen L, Stein D J, DeCaria C, Liebowitz M, Simeon D (1998) Serotonergic function in social phobia: Comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Res 79: 213-217
10. Klieser E, Schulte T, Wurthmann C, Czekalla J, Maestele A, Russ H, Dittman R W, Lehmann E (1999) Open-label study of olanzapine in generalized anxiety disorder (GAD). XI World Congress of Psychiatry, Hamburg, Germany, 6-11 August
11. Leon A C, Shear M K, Portera L, Klerman G L (1992) Assessing impairment in patients with panic disorder: The Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 27: 78-82
12. Liebowitz M R (1987) Social phobia. Mod Probl Pharmacopsychiatry 33: 141-173
13. Liebowitz M R, Stein M B, Tancer M, Carpenter D, Oakes R, Pitts C D (2002) A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. J Clin Psychiatry 63: 66-74
14. Moore N A, Reese G, Sanger G, Tye N C (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5: 196-202
15. Pande A C, Davidson J R, Jefferson J W, Janney C A, Katzelnick D J, Weisler R H, Greist J H, Sutherland S M (1999) Treatment of social phobia with gabapentin: A placebo-controlled study. J Clin Psychopharmacol 19: 341-348
16. Stein M B, Liebowitz M R, Lydiard R B, Pitts C D, Bushnell W, Gergel I (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA 280: 708-713
17. Stein M B, Fyer A J, Davidson J R, Pollack M H, Wiita B (1999) Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. Am J Psychiatry 156: 756-760
18. Tancer M E, Mailman R B, Stein M B, Mason G A, Carson S W, Golden R N (1994-95) Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1: 216-23
19. Tollefson G D, Sanger T M, Beasley C M, Tran P V (1998) A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol Psychiatry 43: 803-810
20. Van Ameringen M, Mancini C, Oakman J M (1999) Nefazodone in social phobia. J Clin Psychiatry 60: 96-100
21. Van Ameringen M A, Lane R M, Walker J R, Bowen R C, Chokka P R, Goldner E M, Johnston D G, Lavallee Y J, Nandy S, Pecknold J C, Hadrava V, Swinson R P (2001) Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. Am J Psychiatry 158: 275-281
22. Versiani M, Nardi A E, Mundim F D, Alves A B, Liebowitz M R, Amrein R (1992) Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360